Browsing Over 443 Presentations

Sort By
Current management of early stage NSCLC Educational session

Current treatment approaches in early disease

Lecture Time
15:10 - 15:30
Speakers
  • R. Califano (Manchester, United Kingdom)
Session Name
Current management of early stage NSCLC
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
  • R. Califano (Manchester, United Kingdom)
My patient has stage IIIA (N2) disease: Surgery or radiotherapy? Multidisciplinary Tumour Board

My patient needs neoadjuivant treatment followed by surgery

Lecture Time
14:40 - 15:07
Speakers
  • W. Eberhardt (Essen, Germany)
Session Name
My patient has stage IIIA (N2) disease: Surgery or radiotherapy?
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
  • W. Eberhardt (Essen, Germany)
Early detection, screening, prevention Educational session

Biomarkers for early detection

Lecture Time
15:42 - 15:57
Speakers
  • N. Peled (Beer Sheva, Israel)
Session Name
Early detection, screening, prevention
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
  • N. Peled (Beer Sheva, Israel)
Early detection, screening, prevention Educational session

Q&A

Lecture Time
15:03 - 15:06
Session Name
Early detection, screening, prevention
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Current management of early stage NSCLC Educational session

Early stage lung cancer: The importance of co-morbidity

Lecture Time
15:30 - 15:50
Speakers
  • A. Toffart (La Tronche, France)
Session Name
Current management of early stage NSCLC
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
  • A. Toffart (La Tronche, France)
Proffered Paper session I Proffered Paper session

Invited Discussant 83O, LBA2 and LBA4

Lecture Time
18:00 - 18:15
Speakers
  • F. Barlesi (Marseille, CEDEX 20, France)
Session Name
Proffered Paper session I
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:15
Authors
  • F. Barlesi (Marseille, CEDEX 20, France)
Optimising treatment in stage III Educational session

Is there only one standard of care in stage III NSCLC?

Lecture Time
16:30 - 16:50
Speakers
  • P. Garrido Lopez (Madrid, Spain)
Session Name
Optimising treatment in stage III
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
  • P. Garrido Lopez (Madrid, Spain)
NSCLC stage IV oncogenic addicted disease Educational session

Current treatment algorithms for EGFR-mutated patients

Lecture Time
16:30 - 16:50
Speakers
  • F. Cappuzzo (Ravenna, Italy)
Session Name
NSCLC stage IV oncogenic addicted disease
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
  • F. Cappuzzo (Ravenna, Italy)
Optimising treatment in stage III Educational session

Integration of I-O in the management of stage III

Lecture Time
16:50 - 17:10
Speakers
  • K. Park (Seoul, Korea, Republic of)
Session Name
Optimising treatment in stage III
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
  • K. Park (Seoul, Korea, Republic of)
NSCLC stage IV oncogenic addicted disease Educational session

Current treatment algorithms for ALK+ and ROS1+ patients

Lecture Time
16:50 - 17:10
Speakers
  • T. Newsom-Davis (London, United Kingdom)
Session Name
NSCLC stage IV oncogenic addicted disease
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
  • T. Newsom-Davis (London, United Kingdom)
Optimising treatment in stage III Educational session

What is the role of surgery for stage III patients in the I-O era?

Lecture Time
17:10 - 17:30
Speakers
  • P. Van Schil (Edegem, Belgium)
Session Name
Optimising treatment in stage III
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
  • P. Van Schil (Edegem, Belgium)
NSCLC stage IV oncogenic addicted disease Educational session

Targeted therapy beyond EGFR, ALK and ROS1

Lecture Time
17:10 - 17:30
Speakers
  • D. Planchard (Villejuif, France)
Session Name
NSCLC stage IV oncogenic addicted disease
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
  • D. Planchard (Villejuif, France)